Related Experiment Video
Updated: Jan 5, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
26.4K
[Experience with divicor used in type 2 diabetes]
A S Ametov1, I I Kochergina1, E P Yelizarova1
1Russian Medical Academy of Postgraduate Education.
Problemy Endokrinologii
|October 20, 2019
Summary
Dibicor is a new metabolic drug that can restore bodily metabolism. It offers positive effects for both diabetes and cardiovascular conditions.
Area of Science:
- Pharmacology
- Metabolic Medicine
- Cardiovascular Science
Context:
- Growing prevalence of diabetes and cardiovascular diseases necessitates novel therapeutic approaches.
- Metabolic dysregulation is a common underlying factor in both diabetes and cardiovascular pathology.
- Limited availability of domestic metabolic drugs presents a challenge in clinical practice.
Purpose:
- To introduce Dibicor, a novel domestic metabolic drug, to the medical community.
- To highlight Dibicor's potential to restore metabolic function.
- To inform physicians about Dibicor's therapeutic benefits for diabetes and cardiovascular conditions.
Summary:
- Dibicor is a newly developed metabolic drug designed to normalize metabolic processes.
- Clinical evidence suggests Dibicor positively influences metabolic parameters relevant to diabetes.
- The drug also demonstrates beneficial effects on cardiovascular health markers.
Impact:
- Dibicor offers a new therapeutic option for managing patients with comorbid diabetes and cardiovascular disease.
- Potential to improve patient outcomes by addressing underlying metabolic dysfunction.
- Contributes to the availability of domestic pharmaceutical solutions for metabolic and cardiovascular disorders.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
01:15Diabetes: Management and Pharmacotherapy
828
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
828
01:22Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
01:20Pathophysiology of Diabetes
3.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.0K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
01:16Insulin: Dosing Regimen and Adverse Effects
631
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
631